Moderna Recursion: Which Cutting-Edge Path Is Best in 2026
Two biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
This guide compares risk profiles of index funds and bonds in retirement, helping you choose allocations that align with your comfort and goals.
28,591 articlesTwo biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
SpaceX's IPO excitement gave way to a pullback, leaving investors wondering about future gains. This guide breaks dow...
Tech stocks pulled back this week as margin risk reemerged amid a cooling chip cycle. Investors who bet on leverage w...
A real-world hotel-charge fraud case highlights how easy it is for card data to be misused. This practical guide show...
Robinhood stock has shown volatility as July 29 earnings approach. This guide breaks down what matters, how to read t...
When a hedge fund disclosed a sizable new stake in Asbury Automotive, the market reacted. This guide breaks down why ...
AngelList is terminating its Rail partnership with Ripple, ending crypto payments on the platform by July 31, 2026. T...
Federal prosecutors say a California couple ran a crypto-laundering operation tied to darknet fentanyl shipments, mov...
Solana faces both headwinds and catalysts as 2026 unfolds. This guide breaks down when to consider solana buy, sell, ...
As BTC consolidates in 2026, Coinbase, BlackRock and Strategy emerge as the top on-chain holders. This report breaks ...
The White House announced the creation of a tech policy advisory council, naming Mark Zuckerberg, Jensen Huang, and L...
The Supreme Court struck down key tariffs under IEEPA, but the administration is weighing strategies to preserve the ...